Vicapsys Life Ownership

VICP Stock  USD 7.00  0.00  0.00%   
Vicapsys Life Sciences shows a total of 31.19 Million outstanding shares. Vicapsys Life Sciences maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Vicapsys Life in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Vicapsys Life, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vicapsys Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Vicapsys Pink Sheet Ownership Analysis

About 46.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 0.02. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Vicapsys Life Sciences recorded a loss per share of 0.03. The entity last dividend was issued on the 2nd of November 2017. The firm had 1:100 split on the 2nd of November 2017. Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN proprietary product. Vicapsys Life Sciences, Inc. was incorporated in 1997 and is based in Suwanee, Georgia. Vicapsys Life operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.The quote for Vicapsys Life Sciences is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call Federico Pier at 972 891 8033 or visit https://vicapsys.com.

Pair Trading with Vicapsys Life

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vicapsys Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vicapsys Life will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Vicapsys Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vicapsys Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vicapsys Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vicapsys Life Sciences to buy it.
The correlation of Vicapsys Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vicapsys Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vicapsys Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vicapsys Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Vicapsys Pink Sheet Analysis

When running Vicapsys Life's price analysis, check to measure Vicapsys Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicapsys Life is operating at the current time. Most of Vicapsys Life's value examination focuses on studying past and present price action to predict the probability of Vicapsys Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicapsys Life's price. Additionally, you may evaluate how the addition of Vicapsys Life to your portfolios can decrease your overall portfolio volatility.